WASHINGTON, DC—Two-year data from the COLOR trial suggest that coronary lesions rich in lipids can be safely treated with PCI, with investigators reporting that revascularization of lipid-rich plaque ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback